| Combination of | |
|---|---|
| Niacin | Vitamin |
| Lovastatin | Statin |
| Clinical data | |
| Pregnancy cat. | X(US) |
| Legal status | ℞-only (US) |
| Routes | Oral |
| Identifiers | |
| ATC code | C10BA01 |
| |
|
Niacin/lovastatin (trade names Advicor, Mevacor) is a drug combination used for the treatment of dyslipidemia. It is a combination of the vitamin niacin and the statin drug lovastatin. The combination preparation is marketed by Abbott Laboratories
It was approved by the FDA on December 17, 2001.
The combination is available as tablets containing:.[1]
|
||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)